Standardized direct disk diffusion antibiotic susceptibility testing on monomicrobial blood cultures is compared with the Food and Drug Administration method. The direct method yields acceptable data and may conserve 24 h in reporting results.
Disk diffusion antibiograms of bacterial blood pathogens are most appropriately determined by the Food and Drug Administration (FDA) recommended procedure (1) (2) (3) (4) Novobiocin (30 ,Lg)
Chloramphenicol (30 ,ug) Isolated colonies from the blood agar plates were used to prepare inocula for the FDA standardized, Bauer-Kirby procedure. Inhibition zone sizes for each isolate and drug tested by the direct and standard procedures were recorded and compared to interpretive standards established for the FDA method (2).
Seventy-four blood cultures containing a single, rapidly growing bacterial pathogen were evaluated. Antibiograms of 16 Staphylococcus aureus, 33 Escherichia coli, 14 Proteus mirabilis, and 11 Klebsiella pneumoniae were obtained by both methods.
Data (Table 1 ) compared for each isolate and antibiotic indicated that the average difference in zone sizes for the two methods was less than 2 mm in all instances and approximately 1 mm in most cases. Results obtained by the two methods necessitated a change in interpretive susceptibility category in only five instances (0.7%).
Attempts have been made in this laboratory to shorten the time required to obtain in vitro susceptibility data on blood pathogens by using the blood culture fluid as inoculum for disk diffusion testing. Results have correlated erratically with data obtained by the accepted technique because of the use of unstandardized inocula and the possible presence of factors influencing zone sizes. This study has shown that inoculation of a relatively tiny sample of blood culture fluid into a relatively large volume of nutrient broth followed by growth to a specific density results in a standardized inoculum and elimination by dilution of factors affecting zone size. This technique is not proposed as a replacement for the FDA method but is presented as a faster alternative method to determine antibiotic susceptibility of blood pathogens in clinically urgent situations.
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